Trial Profile
Efficacy and safety of sofosbuvir plus simeprevir in patients with advanced HCV cirrhosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Sep 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C; Liver cirrhosis
- Focus Therapeutic Use
- 15 Sep 2015 New trial record